Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Phathom Pharmaceuticals Clarifies That Scheduled 13D Filing By Frazier Life Sciences Includes Administration Changes To Reporting Approach But Does Not Represent Reduction In Ownership Position Of Any Frazier Fund Or Person In Phantom

Author: Benzinga Newsdesk | August 20, 2025 07:07am

Posted In: PHAT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist